Na Hyun-hee, Vice President of JNP Medi (CEO Jeong Kwon-ho, JNP Medi), and Lee Seong-kyung, Head of the Science and Business Development Center, have been appointed as members of the Technology Transfer Committee for the 26th year of the Pharmaceutical Industry Technology Transfer Center.
The appointment ceremony took place during the '26th Annual Technology Transfer Committee Launch Ceremony and Appointment Certificate Presentation Ceremony of the Pharmaceutical Industry Technology Transfer Center,' held last month at the Samjung Hotel in Gangnam-gu, Seoul. The event was hosted by the Korea Drug Research Association and organized by the Pharmaceutical Industry Technology Transfer Center, with 155 experts from 94 pharmaceutical and bio-health related companies and institutions participating in the committee. Forty-two individuals from 30 companies received letters of appointment as new or replaced members.
At JNP Medi, Vice President Na Hyun-hee of the Clinical Strategy Development Group and Director Lee Seong-kyung of the Science and Business Development Center have been appointed as members. They are set to participate in the activities of the Technology Transfer Committee based on the company's capabilities in clinical strategy, business development, and regulatory compliance. In particular, they are expected to contribute to expanding cooperation within the industry by connecting the technological needs of pharmaceutical and biotech companies with promising technologies, and by reviewing potential linkages for joint research and investment.
In addition, the two executives plan to support opportunities for inter-company cooperation and technology commercialization by participating in various technology trading activities, such as technology briefings, partnering programs, and global cooperation projects.
Center Director Lee Seong-kyung stated, “Through this appointment, we will maximize the value of promising domestic pipelines by integrating JNP Medi’s clinical strategy and business development expertise into the entire technology transfer process,” adding, “By going beyond simple technology matching to provide integrated solutions covering clinical trials and regulatory responses, we will play a role in increasing the market success potential of innovative technologies within the pharmaceutical and bio industries.”
Meanwhile, in the pharmaceutical and biotechnology industries, there has recently been active movement to support inter-company cooperation and the commercialization of promising technologies through the Technology Transfer Commission.
- See more related articles
You must be logged in to post a comment.